SCOLARI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 27.071
EU - Europa 17.725
AS - Asia 14.376
SA - Sud America 3.198
Continente sconosciuto - Info sul continente non disponibili 590
AF - Africa 515
OC - Oceania 88
Totale 63.563
Nazione #
US - Stati Uniti d'America 26.410
PL - Polonia 5.850
CN - Cina 4.729
SG - Singapore 4.410
UA - Ucraina 3.597
IT - Italia 2.721
BR - Brasile 2.682
HK - Hong Kong 2.052
DE - Germania 1.434
FI - Finlandia 1.128
VN - Vietnam 1.089
FR - Francia 777
GB - Regno Unito 584
TR - Turchia 582
RU - Federazione Russa 505
IE - Irlanda 496
CA - Canada 325
BD - Bangladesh 280
IN - India 275
NG - Nigeria 241
JP - Giappone 211
AR - Argentina 204
NL - Olanda 174
ID - Indonesia 168
MX - Messico 140
IQ - Iraq 109
SE - Svezia 95
AU - Australia 86
EC - Ecuador 80
ZA - Sudafrica 75
CO - Colombia 66
ES - Italia 61
PK - Pakistan 54
MA - Marocco 48
SA - Arabia Saudita 48
AT - Austria 45
PY - Paraguay 43
CZ - Repubblica Ceca 42
VE - Venezuela 39
UZ - Uzbekistan 35
MY - Malesia 34
BE - Belgio 31
IL - Israele 31
CL - Cile 30
EG - Egitto 29
CR - Costa Rica 28
JO - Giordania 26
PE - Perù 26
EU - Europa 25
LT - Lituania 25
JM - Giamaica 24
KE - Kenya 24
IR - Iran 23
TT - Trinidad e Tobago 23
CH - Svizzera 22
TW - Taiwan 22
HN - Honduras 20
KZ - Kazakistan 20
TN - Tunisia 20
KR - Corea 19
NP - Nepal 18
AE - Emirati Arabi Uniti 17
AL - Albania 16
AZ - Azerbaigian 16
GT - Guatemala 16
PH - Filippine 16
SV - El Salvador 16
UY - Uruguay 16
PA - Panama 15
DZ - Algeria 14
PS - Palestinian Territory 14
LV - Lettonia 13
PR - Porto Rico 13
SC - Seychelles 13
TH - Thailandia 13
ET - Etiopia 12
RO - Romania 12
KG - Kirghizistan 11
NI - Nicaragua 11
PT - Portogallo 11
RS - Serbia 11
BO - Bolivia 10
DO - Repubblica Dominicana 10
EE - Estonia 9
AM - Armenia 8
BB - Barbados 8
BG - Bulgaria 8
GR - Grecia 8
LB - Libano 8
MU - Mauritius 8
DK - Danimarca 7
HU - Ungheria 7
OM - Oman 7
SN - Senegal 7
CW - ???statistics.table.value.countryCode.CW??? 6
MK - Macedonia 6
BY - Bielorussia 5
HR - Croazia 5
NO - Norvegia 5
BW - Botswana 4
Totale 62.922
Città #
Warsaw 5.826
Jacksonville 2.281
Singapore 2.244
Ashburn 2.159
Hong Kong 2.014
Fairfield 2.009
Woodbridge 1.997
San Jose 1.386
Houston 1.195
Council Bluffs 1.072
Princeton 977
The Dalles 956
Ann Arbor 926
Cambridge 879
Beijing 828
Wilmington 769
Seattle 764
Nanjing 740
Helsinki 648
Dublin 489
Columbus 465
Istanbul 459
Los Angeles 441
Lauterbourg 431
New York 408
Chandler 398
Milan 336
Ho Chi Minh City 324
Nanchang 296
Des Moines 241
Abuja 238
São Paulo 238
Buffalo 226
Dong Ket 216
Moscow 201
Redondo Beach 186
Changsha 185
Santa Clara 184
Shenyang 178
Hebei 176
Franklin 165
Dallas 162
Hanoi 157
Brescia 156
Chicago 147
Phoenix 141
Munich 128
Dearborn 127
San Diego 124
Memphis 121
Rome 121
Tianjin 116
Shanghai 114
Jiaxing 110
San Francisco 103
Toronto 103
Hangzhou 100
Rio de Janeiro 98
Jinan 90
Tokyo 88
North Bergen 85
Orem 85
Atlanta 80
Verona 79
Jakarta 76
Brooklyn 74
London 69
Nuremberg 67
Montreal 63
Kocaeli 60
Kunming 57
Guangzhou 53
Belo Horizonte 46
Chennai 46
Boston 44
Denver 43
Brasília 42
Lanzhou 41
Baghdad 40
Naples 40
Paris 40
Bologna 39
Curitiba 39
Washington 39
Frankfurt am Main 38
Ningbo 38
Zhengzhou 36
Turku 35
Melbourne 34
Porto Alegre 34
Redwood City 34
Springfield 33
Palermo 32
Amsterdam 31
Campinas 31
Dhaka 31
Florence 31
Las Vegas 31
Mumbai 31
Norwalk 31
Totale 40.335
Nome #
The pathophysiology of IgA nephropathy 1.043
Trattamento del linfocele postoperatorio mediante instillazione su guida ecografica di polivinil-pirrolidone iodico. Casistica personale. 914
Genome-wide association study identifies susceptibility loci for IgA nephropathy 553
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 521
Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure. 347
The copy number variation landscape of congenital anomalies of the kidney and urinary tract. 324
Suprarenal aortic cross-clamping in the elective surgery of abdominal aortic aneurysms. Lessons from 68 cases out of consecutive survey of 746 abdominal aortic substitutions. 310
Autoimmunity in membranous nephropathy targets aldose reductase and SOD2 308
Genetic drivers of kidney defects in the digeorge syndrome 305
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway 301
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23 295
Atheroembolic renal disease 293
Insufficienza renale acuta e o subacuta richiedente dialisi in corso di malattia ateroembolica renale: impatto sulla sopravvivenza del paziente e del rene. 281
The importance of skin biopsy in the diverse clinical manifestations of cholesterol embolism. 279
Mutations in DSTYK and dominant urinary tract malformations. 278
Defective intracellular trafficking of uromodulin mutant isoforms 274
Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin 271
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) 271
A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13. 271
PREDICTORS OF RENAL AND PATIENT OUTCOMES IN ATHEROEMBOLIC RENAL DISEASE: A PROSPECTIVE STUDY. 268
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 266
Uromodulin storage diseases: clinical aspects and mechanisms. 265
Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study 265
Infertility and hypergonadotropic hypogonadism as first evidence of hereditary apolipoprotein A-I amyloidosis 263
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. 263
CHOLESTEROL CRYSTAL EMBOLISM: A RECOGNIZABLE CAUSE OF RENAL DISEASE 261
Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations. 261
IgA nephropathy: the presence of familial disease does not confer an increased risk for progression 260
Lack of association between dialysis modality and outcomes in atheroembolic renal disease 258
Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal diseases 257
The Case | Cystic renal disease, nephrogenic diabetes insipidus, and polycytemia. 255
Renal outcome in patients with congenital anomalies of the kidney and urinary tract. 253
Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. 251
Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families 249
Malattia cistica della midollare (MCKD), Nefropatia iperuricemica familiare giovanile (FJHN) e Glomerulocisti (GCKD) sono causate da mutazioni dello stesso gene (UMOD) che determinano alterazioni del trasporto cellulare di uromodulina. 249
Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. 248
Urinary secretion and extracellular aggregation of mutant uromodulin isoforms 248
Autosomal Dominant tubulointerstitial Kidney Disease with Adult onset due to a novel Renin Mutation Mapping in the Mature protein 247
The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. 246
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 246
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial. 245
Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. 244
Familial vesicoureteral reflux: testing replication of linkage in seven new multigenerational kindreds 240
Coexistence of Different Circulating Anti-PodocyteAntibodies in Membranous Nephropathy 239
Genetic studies of IgA nephropathy: past, present, and future. 238
IgA nephropathy--the case for a genetic basis becomes stronger. 238
Phenotypic expansion of DGKE-associated diseases. 234
Copy number disorders are a Common Cause of Congenital Kidney Malformations 230
Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection. 230
Localization of a gene for nonsyndromic renal hypodysplasia to chromosome 1p32-33. 229
Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis 229
Search for genetic association between IgA nephropathy and candidate genes selected by function or by gene mapping at loci IGAN2 and IGAN3 225
Genetic approaches to human renal agenesis/hypoplasia and dysplasia. 224
The Case ∣ Familial occurrence of retinitis pigmentosa, deafness, and nephropathy. 216
The progression from obesity to type 2 diabetes in Alström syndrome. 216
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: Protocol of a pilot randomised controlled trial 206
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 205
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 204
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 202
Uromodulin: from monogenic to multifactorial diseases. 202
Glomerular clusterin is associated with PKC-alpha/beta regulation and good outcome of membranous glomerulonephritis in humans 201
Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. 201
A long term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies. 201
Anemia emolitica autoimmune acquisita (AEAA) da incompatibilità minore ABO: un raro esempio di graft versus host disease (GVHD) in corso di trapianto di rene (TX). 200
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 198
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model 198
Berger's Disease 197
IDENTIFICATION OF A NEW LOCUS FOR MEDULLARY CYSTIC DISEASE ON CHROMOSOME 16 188
A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease 186
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection 185
ORO-FACIO-DIGITAL SYNDROME 180
LES FORMES FAMILIALES DE NÉPHROPATHIE À IgA ÉTUDES CLINIQUE ET GÉNÉTIQUE 178
Ciclosporin in renal transplantation: identification of two populations with different drug metabolism. 176
AUTOSOMAL DOMINANT MEDULLARY CYSTIC KIDNEY DISEASE 176
The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors 172
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 171
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 170
Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism 169
Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis. 167
La sindrome oro-facio-digitale tipo 1: una causa infrequente di malattia cistica renale a carattere ereditario. 165
Non-collagen genes role in digenic Alport syndrome 164
Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. 163
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy 161
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 160
Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. 159
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 157
Familial IgM mesangial nephropathy: a morphologic and immunogenetic study of three pedigrees. 157
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes 157
32 cases of familial primary glomerulonephritis: HLA do not play a role in the genetic mechanism of the disease. 156
[Hyperuricemia and Gout] 156
[The role of magnetic resonance angiography in the assessment of arterial stenosis in the transplanted kidney] 156
Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. 155
Familial occurrence of primary glomerulonephritis: evidence for a role of genetic factors. 155
Early histopathologic changes predicting long-term kidney transplant survival. 154
The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex trait 154
Immunogenetics of Henoch-Schoenlein disease. 154
Clustering familiare di differenti forme di glomerulonefrite primitiva: studio Valtrompia: 153
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 152
Viral hepatitis in HBsAg-positive renal transplant patients treated with cyclosporin and steroids. 151
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. 150
Totale 24.117
Categoria #
all - tutte 281.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 281.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.080 0 0 0 0 55 92 171 201 171 338 283 769
2022/20231.956 517 20 32 100 117 641 6 144 192 17 89 81
2023/20242.773 103 49 152 243 77 271 121 80 1.018 44 63 552
2024/20257.290 48 46 53 836 964 574 973 199 720 385 1.581 911
2025/202616.320 1.268 2.310 1.454 2.618 1.209 966 2.504 704 1.062 1.224 721 280
2026/20275.754 985 766 1.516 1.927 560 0 0 0 0 0 0 0
Totale 63.563